Tamoxifen is a nonsteroidal triphenylethyl compound that is widely used as adjuvant therapy in the treatment of breast cancer. Tamoxifen prolongs overall and disease-free survival, reduces the ...

April 26, 2011 (New York, New York) — A metaanalysis of women who have had polypectomies suggests that postmenopausal status and abnormal bleeding are negatively associated with endometrial neoplasia.

Q: My gynecologist told me my vaginal bleeding may be from polyps inside my uterus. Is this common? How will she know for sure if I have polyps? Is this a type of cancer? What kind of treatments are ...

An endometrial polyp is an overgrowth of the endometrial lining on the inside of the uterine cavity, most often found in women between 20 and 40 years of age. It contains no muscular tissue unlike a ...

APPROXIMATELY 80,000 OF the 182,000 women diagnosed annually with breast cancer in the United States will be started on tamoxifen as part of their treatment. Although the expected annual risk of ...

Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...

(HealthDay News) — For women with abnormal uterine bleeding and hysteroscopically diagnosed endometrial polyps, outpatient treatment is more cost-effective than inpatient treatment, according to ...

There’s no doubt that women’s healthcare has been seriously understudied and underfunded for far too long. Many of us have heard terms like uterine fibroids and ovarian cysts, but few of us — unless ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...